ライフサイエンスコーパス: echocardiographic

1 enic events also had no excess of minor-risk echocardiographic abnormalities (cryptogenic 37% vs 45%;

2 lation [AF] during follow-up, and minor-risk echocardiographic abnormalities and subclinical paroxysm

3 sudden death without electrocardiographic or echocardiographic abnormalities at rest.

4 The prevalence of echocardiographic abnormalities was significantly higher

5 Carotid artery and echocardiographic abnormalities, and incidence of transi

6 bundle branch block morphology and no ECG or echocardiographic abnormalities.

7 so display greater structural and functional echocardiographic abnormalities.

8 Echocardiographic analysis of pressure overloaded hearts

9 Serial echocardiographic analysis reveals that within 2 weeks o

10 SOL (Echocardiographic Study of Latinos), an echocardiographic ancillary study of the HCHS/SOL (Hispa

11 Current echocardiographic and cardiovascular magnetic resonance

12 Echocardiographic and catheterization data were obtained

13 The study aimed to identify early echocardiographic and circulating biomarkers of heart fa

14 Echocardiographic and clinical data of patients with mod

15 No study has analyzed the long-term echocardiographic and clinical follow-up of this subgrou

16 The 2 groups had similar baseline echocardiographic and electrocardiographic characteristi

17 Echocardiographic and electrocardiographic findings were

18 Pre-natal echocardiographic and final diagnoses were compared.

19 iously published scores and known individual echocardiographic and hemodynamic markers of RHF.

20 study, we looked at the prognostic value of echocardiographic and hemodynamic measures in a large co

21 Further, echocardiographic and immunohistochemical analyses of re

22 Doppler echocardiographic and invasive measures of mean right at

23 Agreement between echocardiographic and invasive measures of pulmonary pre

24 In general, correlations between echocardiographic and invasive parameters were better in

25 Conventional echocardiographic and parametrized diastolic filling sti

26 nI) concentrations and electrocardiographic, echocardiographic, and clinical characteristics were ass

27 Clinical, echocardiographic, and exercise variables (metabolic equ

28 ng data extracted from clinical, laboratory, echocardiographic, and genetic assessments.

29 Clinical, biochemical, echocardiographic, and hemodynamic correlates were studi

30 he IE Study Group according to the clinical, echocardiographic, and microbiologic findings.

31 Electrocardiographic, echocardiographic, and serum biomarkers of cardiac damag

32 fore cardiac MRI was calculated as change in echocardiographic aortic root diameter z score per year.

33 ctive measurement of BNP levels with Doppler echocardiographic AS assessment during the same episode

34 agnosis, independent of clinical and Doppler echocardiographic AS characteristics, has not been studi

35 rmed comprehensive clinical, laboratory, and echocardiographic assessment in 245 patients with HF.

36 Echocardiographic assessment included 3-dimensional (3D)

37 left ventricular EF of <35% and a follow-up echocardiographic assessment of EF at 12 months.

38 easures of coronary artery calcification and echocardiographic assessment of left ventricular systoli

39 All patients underwent core laboratory echocardiographic assessment of LVEF at baseline, post p

40 Comprehensive 2-dimensional echocardiographic assessment, 3D-ST of the RV free wall,

41 y were assessed by clinical, laboratory, and echocardiographic assessments performed at pre-, mid- an

42 ent clinically relevant changes were seen in echocardiographic cardiac assessments.

43 A total of 400 paired echocardiographic cardiac output and MostCare cardiac ou

44 A significant correlation was found between echocardiographic cardiac output and MostCare cardiac ou

45 ng the different ICUs, the mean bias between echocardiographic cardiac output and MostCare cardiac ou

46 One echocardiographic cardiac output measurement was compare

47 t values ranged from 1.95 to 9.90 L/min, and echocardiographic cardiac output ranged from 1.82 to 9.7

48 Simultaneous echocardiographic-catheterization studies were prospecti

49 We examined clinical and echocardiographic characteristics and outcomes in the I-

50 howed that young and aged HCM mice displayed echocardiographic characteristics of the heart disease c

51 between baseline biomarkers, demographic and echocardiographic characteristics, change in primary (ch

52 c information over clinical and conventional echocardiographic characteristics.

53 This early descriptive study shows that echocardiographic chararacteristics of both the right an

54 Clinical, echocardiographic, computed tomographic, and angiographi

55 duct labeling for the commercially available echocardiographic contrast agents (ECA) Definity and Opt

56 Echocardiographic core analysis after 6 months showed mi

57 An independent echocardiographic core laboratory evaluated all echocard

58 The clinical events committee and echocardiographic core laboratory methods were the same

59 valve surgery is often made on the basis of echocardiographic criteria and clinical assessment.

60 n the community using current, more specific echocardiographic criteria is unknown.

61 Among the 6 different echocardiographic criteria, first tested in a preliminar

62 cific training), and (3) a simplified set of echocardiographic criteria.

63 derlying CIED infection based on clinical or echocardiographic criteria.

64 months, and 21 (66%) demonstrated a positive echocardiographic CRT response (>/=5% absolute increase

65 Addition of exercise echocardiographic data (E/e' ratio>14) improved sensitiv

66 Baseline clinical and echocardiographic data (including LV-GLS using Velocity

67 ity improvement (CQI) approaches to increase echocardiographic data accuracy and reliability.

68 asively proven HFpEF on the basis of resting echocardiographic data alone.

69 METHODS AND Demographic, clinical, and echocardiographic data at first presentation of 1992 pat

70 framework that incorporates speckle-tracking echocardiographic data for automated discrimination of h

71 amined myocardial tissue and hemodynamic and echocardiographic data from 44 LVAD patients and 18 untr

72 Clinical and echocardiographic data of 50 patients with constrictive

73 Clinical and echocardiographic data were analyzed in overall populati

74 Clinical and echocardiographic data were analyzed retrospectively.

75 Clinical and echocardiographic data were analyzed to identify early r

76 Follow-up data and baseline echocardiographic data were available for 2,713 patients

77 Echocardiographic data were available in 745 patients an

78 teristics, implant strategies, hemodynamics, echocardiographic data, and outcomes were compared.

79 o both cardiovascular magnetic resonance and echocardiographic data.

80 mas in the pathology database and 142 in the echocardiographic database.

81 ruction of the 3-dimensional transesophageal echocardiographic dataset at baseline revealed a tricusp

82 Expert-annotated speckle-tracking echocardiographic datasets obtained from 77 ATH and 62 H

83 cular ejection fraction, we identified other echocardiographic-derived variables predictive for SCD t

84 Early diagnosis and echocardiographic detection of right ventricular (RV) dy

85 Echocardiographic determination of ejection fraction (EF

86 A total of 113 patients with an echocardiographic diagnosis of LVNC underwent CMR at 5 r

87 has recently published new criteria for the echocardiographic diagnosis of RHD.

88 ppreciation of cardiac wall thickness, early echocardiographic diagnosis, and swift referral for card

89 agement of aortic stenosis rests on accurate echocardiographic diagnosis.

90 oon-stretched diameter >/=34 mm in adults or echocardiographic diameter >15 mm/m(2) in children) were

91 However, the clinical and echocardiographic differences according to functional TR

92 e sought to identify whether a new composite echocardiographic Doppler marker of the LV ejection acco

93 elopment of defective systolic and diastolic echocardiographic/Doppler parameters developing in the h

94 ailure, we evaluated the correlation between echocardiographic EAT thickness and cardiac adrenergic n

95 alysis Quality Initiative Workgroup proposed echocardiographic (ECHO) criteria for structural heart d

96 Echocardiographic, electrocardiographic, and invasive he

97 Baseline RV function was assessed by echocardiographic end-diastolic area, end-systolic area,

98 Agreement between MRI and echocardiographic estimates of MR severity was modest in

99 All participants had a complete echocardiographic evaluation at baseline and at 1-year f

100 ar, with assessment of clinical outcomes and echocardiographic evaluation of valve function.

101 At hospital discharge, echocardiographic evaluation revealed trace residual MR

102 ed cardiac output in 400 patients in whom an echocardiographic evaluation was performed as a routine

103 tely powered prospective study with thorough echocardiographic evaluation will be critical.

104 rning and recalling patterns observed during echocardiographic evaluations.

105 patients with a QRS duration of <130 ms and echocardiographic evidence of left ventricular dyssynchr

106 Group 2 (n = 326) patients had echocardiographic evidence of PFE but no cardiac surgery

107 asymptomatic and had a normal transthoracic echocardiographic examination without signs of thrombus

108 on, recognition of discordant data within an echocardiographic examination, and proper interpretation

109 The reference approach used standardized echocardiographic examination, reviewed by an expert car

110 We sought to compare the quality of echocardiographic examinations performed at accredited v

111 Echocardiographic examinations were performed at dischar

112 A combination of clinical and echocardiographic features can reliably diagnose BPVT.

113 The samples from subjects with atypical echocardiographic features of amyloidosis showed quantit

114 whether patients with cryptogenic stroke and echocardiographic features representing risk of stroke w

115 In contrast, former smokers showed similar echocardiographic features when compared with never smok

116 Demographic and clinical characteristics and echocardiographic findings at presentation, as well as c

117 Study compared clinical outcomes and serial echocardiographic findings in patients with severe aorti

118 Echocardiographic findings included a markedly elevated

119 pment of atrial fibrillation, fluid balance, echocardiographic findings, medication administration, a

120 a cardiac assist device and is compared with echocardiographic findings.

121 based on the yielding of blood cultures and echocardiographic findings.

122 ce of clinical symptoms of heart failure and echocardiographic findings.

123 Mean echocardiographic follow-up was 20 +/- 13 months (minimu

124 Echocardiographic follow-up was available in 10 survivor

125 recent analysis involving a more systematic echocardiographic follow-up, the advent of transcatheter

126 e retrospectively analyzed with longitudinal echocardiographic follow-up.

127 RV function per echocardiographic fractional area change at presentation

128 contractile function using speckle-tracking echocardiographic global circumferential strain (GCS) fr

129 Closure can be performed under transthoracic echocardiographic guidance in experienced centers.

130 septal catheterisation with transoesophageal echocardiographic guidance under general anaesthesia.

131 Transthoracic echocardiographic guidance was used starting in 2005 (n=

132 ction was investigated with fluoroscopic and echocardiographic guidance, with delivery visualized by

133 nder general anesthesia with transesophageal echocardiographic guidance.

134 safety and performance of a transesophageal echocardiographic-guided device designed to implant arti

135 Echocardiographic, hemodynamic, and histological evaluat

136 tion abnormalities, and 5 of 27 (19%) showed echocardiographic hypokinesis of the lateral LV wall.

137 luated for its geometric valve orifice area, echocardiographic image quality, and aortic stenosis sev

138 llow-up of patients with KD, especially when echocardiographic images are limited or technically chal

139 ts with LVSD had both pre- and postoperative echocardiographic images available for review by 2 blind

140 d age, sex, race, ethnicity, height, weight, echocardiographic images, and measurements performed at

141 Electrocardiograms, echocardiographic images, and videos presented in this r

142 LV short-axis echocardiographic images, LV stroke volume, and dP/dtmax

143 based system for automated interpretation of echocardiographic images, which may help novice readers

144 iew attempts to summarize the procedures and echocardiographic imaging used for transcatheter valve r

145 aluation based on clinical findings, precise echocardiographic imaging, and when necessary, adjunctiv

146 circulation and showed improvement in repeat echocardiographic imaging.

147 ardiographic progression and 45.2% and 46.3% echocardiographic improvement, respectively.

148 ch patient, and total isovolumic time is the echocardiographic index with the highest sensitivity to

149 with control subjects and is associated with echocardiographic indexes of diastolic dysfunction.

150 cedure, TAVR was noninferior with respect to echocardiographic indexes of valve stenosis, functional

151 We used robust echocardiographic indices to characterize left ventricul

152 h studies used similar protocol, centralized echocardiographic interpretation, and measures expressed

153 Further echocardiographic investigation led to the discovery of

154 Accredited echocardiographic laboratories had more complete reporti

155 It is presumed that echocardiographic laboratory accreditation leads to impr

156 ic regurgitation evaluated by an independent echocardiographic laboratory.

157 Echocardiographic left ventricular ejection fraction cha

158 index, carotid intimal-medial thickness, and echocardiographic left ventricular hypertrophy and systo

159 Multiple echocardiographic LV diastolic parameters demonstrated w

160 io of LVWT to diastolic diameter, and higher echocardiographic LV ejection fraction than controls.

161 on analysis was used to assess the impact of echocardiographic LV mass on rate of major cardiovascula

162 P < 0.005) and correlated with LV E/e' as an echocardiographic marker of diastolic dysfunction (r = 0

163 ere and mild/moderate AS) according to their echocardiographic mean pressure gradient.

164 ltivariable model, RWT was the most powerful echocardiographic measure for estimating the risk of VAs

165 ntricular midwall strain represents a simple echocardiographic measure, which might be used for asses

166 Echocardiographic measurements (TA diameter, effective r

167 Published nomograms of pediatric echocardiographic measurements are limited by insufficie

168 ficant because interobserver variability for echocardiographic measurements are reported as >/=5% dif

169 aim of this study was to assess the role of echocardiographic measurements at rest and during exerci

170 Cardiac effects were assessed by echocardiographic measurements of left ventricular funct

171 Echocardiographic measurements of LV geometry and functi

172 Echocardiographic measurements of myocardial function su

173 ariable Cox regression and correlations with echocardiographic measurements performed.

174 Noninvasive echocardiographic measurements showed that left ventricu

175 Echocardiographic measurements showed that, although lep

176 -perfused hearts and in vivo hemodynamic and echocardiographic measurements, we demonstrate that ELA

177 rglycemia along with significant deficits in echocardiographic measurements.

178 ities, valve pathophysiologic disorders, and echocardiographic measurements: robotic vs sternotomy (1

179 aluated the relationship between smoking and echocardiographic measures in a large elderly cohort.

180 LV filling was impaired by echocardiographic measures in all patients, including a

181 nical, laboratory, electrocardiographic, and echocardiographic measures in participants in the ARIC s

182 with respect to CVD prevalence (n=6520) and echocardiographic measures of cardiac structure and func

183 We aimed to assess the relationship between echocardiographic measures of cardiac structure and func

184 modality approach that combines the relevant echocardiographic measures of diastolic function with bl

185 nd circulating adipokine concentrations with echocardiographic measures of LV mechanical function amo

186 n between AF and LVH were based primarily on echocardiographic measures of LVH.

187 PH and higher TRV and PASP (echocardiographic measures of PH) are associated with ad

188 ry end points included changes in LV volume, echocardiographic measures of systolic and diastolic fun

189 For grade A TR signals, echocardiographic measures of systolic pulmonary arteria

190 the study population overall, and change in echocardiographic measures was associated with the subse

191 Associations between HAART exposure and echocardiographic measures were evaluated using generali

192 Cubans had highest values of echocardiographic measures, and Central Americans had th

193 roves survival, quality of life, and several echocardiographic measures.

194 es in HFpEF beyond clinical and conventional echocardiographic measures.

195 eometries that are not assessable by current echocardiographic measures.

196 ent of AS severity in comparison to clinical echocardiographic measures.

197 Multiple echocardiographic methods are used to measure left ventr

198 ed to cirrhosis can be assessed using robust echocardiographic methods.

199 One hundred nine asymptomatic patients with echocardiographic moderate or severe mitral regurgitatio

200 close clinical examination and 2-dimensional echocardiographic monitoring.

201 Although the rates of echocardiographic normalization (30% and 27%) and heart

202 ifference in the proportion of children with echocardiographic normalization at 3 years of follow-up

203 mulative incidence of death, transplant, and echocardiographic normalization by cohort and to identif

204 Echocardiographic observational study of NBA players on

205 s embryonic anomaly may be detected by fetal echocardiographic or newborn ultrasound examinations.

206 m of this study was to evaluate clinical and echocardiographic outcome data at longer term follow-up.

207 e effect of PPM implantation on clinical and echocardiographic outcomes after transcatheter aortic va

208 This article reports 2-year clinical and echocardiographic outcomes from the NOTION trial.

209 Clinical and echocardiographic outcomes of patients who underwent red

210 without BAVP, provided similar clinical and echocardiographic outcomes over a midterm follow-up alth

211 Clinical and echocardiographic outcomes were assessed at baseline, di

212 Clinical and echocardiographic outcomes were assessed at baseline, po

213 were followed for 2 years, and clinical and echocardiographic outcomes were assessed.

214 The 2-year clinical and echocardiographic outcomes were evaluated in these patie

215 Clinical and echocardiographic outcomes were obtained at 6, 12, 24, a

216 Three-year clinical and echocardiographic outcomes were obtained in those patien

217 s were followed for 2 years for clinical and echocardiographic outcomes.

218 ith favorable acute and midterm clinical and echocardiographic outcomes.

219 ost-CRT changes in QRS duration (P = 0.006), echocardiographic (P = 0.03) and ERNA LVEF (P = 0.0007),

220 No preoperative echocardiographic parameter predicted HF in affected pat

221 stic information for VT/VF over clinical and echocardiographic parameters (C statistic 0.71 versus 0.

222 These 3 doses had similar effects on echocardiographic parameters (infarct wall thickening fr

223 In this minority, conventional echocardiographic parameters alone are insufficient to d

224 AF is associated with changes in echocardiographic parameters and circulating natriuretic

225 lore various clinical diagnostic modalities, echocardiographic parameters for assessment of shunt pre

226 ative T1 times and TBPC were correlated with echocardiographic parameters of diastolic function.

227 We aimed to define the changes in echocardiographic parameters of structure, function, and

228 We evaluated changes in echocardiographic parameters over time, and used repeate

229 significant changes in most biochemical and echocardiographic parameters suggests that further evalu

230 nt of fluid responsiveness relies on dynamic echocardiographic parameters that have not yet been comp

231 Traditional echocardiographic parameters to evaluate systolic ventri

232 Secondary endpoints included changes in echocardiographic parameters, overall mortality, the com

233 Among echocardiographic parameters, we measured global longitu

234 1), but not with S (rs=0.07, P=0.5) or other echocardiographic parameters.

235 Second, echocardiographic PH (based on variable definitions) has

236 rdiographic variables identified 3 different echocardiographic phenotypes of T2DM patients that were

237 rmed detailed clinical, laboratory, ECG, and echocardiographic phenotyping of the study participants.

238 LS was the strongest echocardiographic predictor of the composite outcome.

239 of impaired contraction before the event or echocardiographic predictors of HF were masked by circul

240 .35-6.04; P=0.004) were the only independent echocardiographic predictors of in-hospital mortality in

241 Independent echocardiographic predictors of mortality were identifie

242 This study assessed the echocardiographic predictors of sudden cardiac death (SC

243 h moderate-to-severe definite RHD, 47.6% had echocardiographic progression (including 2 deaths), and

244 inite and borderline RHD showed 26% and 9.8% echocardiographic progression and 45.2% and 46.3% echoca

245 te reporting and better image quality, while echocardiographic quantification and color Doppler image

246 Reference limits for echocardiographic quantification of cardiac chambers in

247 ce of high-quality color Doppler imaging and echocardiographic quantification to improve the accuracy

248 5%) had baseline SSI quantified by automated echocardiographic radial strain analysis.

249 els compared with controls, whereas standard echocardiographic readouts, including fractional shorten

250 ogression (including 2 deaths), and 9.5% had echocardiographic regression.

251 Completeness and quality of echocardiographic reports and images were assessed by in

252 -one patients had ABPM, and 142 patients had echocardiographic results available for analysis.

253 n independent clinical events committee, and echocardiographic results were analyzed by a core labora

254 59 patients with acute Q fever and available echocardiographic results, 9 (1.2%) were considered to h

255 %) were given a diagnosis of PH on the basis echocardiographic results.

256 external laboratory accreditation status and echocardiographic results.

257 tal prognostic information over clinical and echocardiographic risk factors in predicting ventricular

258 ared with a model with clinical and standard echocardiographic risk factors.

259 ment cardiac magnetic resonance imaging, and echocardiographic RV deformation imaging.

260 Echocardiographic screening must be supplemented with sc

261 onal flow velocity fields from color Doppler echocardiographic sequences were obtained in 20 patients

262 We compared measurements of echocardiographic SIC with validated assessments of card

263 he accuracy, reproducibility, and quality of echocardiographic studies for valvular heart disease.

264 Clinical assessments, echocardiographic studies, 12-lead electrocardiograms, 2

265 METHODS AND We conducted a prospective echocardiographic study in 756 healthy children (aged 1

266 We performed a complete echocardiographic study including tissue Doppler imaging

267 s aged 45 to 74 years were enrolled into the Echocardiographic Study of Latinos (ECHO-SOL) and underw

268 hy was performed in 1818 participants of the Echocardiographic Study of Latinos (ECHO-SOL).

269 ECHO-SOL (Echocardiographic Study of Latinos), an echocardiographi

270 uthors performed a combined mathematical and echocardiographic study to understand the inconsistencie

271 A comprehensive baseline echocardiographic study was performed at the clinician s

272 Finally, in the echocardiographic subcohort, a left ventricular ejection

273 nths, highlighting their need for heightened echocardiographic surveillance and suggesting that this

274 support speckle tracking as a postprocessing echocardiographic technique to detect uremic cardiomyopa

275 echocardiographic vector flow mapping, a new echocardiographic technique, would provide insights into

276 literature exploring the utility of advanced echocardiographic techniques (such as deformation imagin

277 Advanced ECG signal processing, echocardiographic techniques, and MRI imaging of fibrosi

278 As bedside echocardiographic technology becomes more rapidly and re

279 sectional 3-dimensional (3D) transesophageal echocardiographic (TEE) measurements to severely underes

280 We related the CVH score to echocardiographic traits cross-sectionally and to HF inc

281 A GWAS meta-analysis of echocardiographic traits was performed, including 46,533

282 Transthoracic echocardiographic (TTE) surveillance of patients with mi

283 Echocardiographic, urine, and blood evaluations were con

284 r complications, bleeding complications, and echocardiographic valve parameters.

285 covariates to assess the association between echocardiographic variables and SCD, adjusting for Frami

286 Whether echocardiographic variables can predict prognosis in S a

287 ; the full multivariable model including all echocardiographic variables had a C statistic of 0.76 fo

288 Cluster analysis of echocardiographic variables identified 3 different echoc

289 A range of clinical and echocardiographic variables were collected and stored on

290 Five principal echocardiographic variables were selected based on prior

291 A cluster analysis was performed on echocardiographic variables, and the association between

292 the risk of VAs compared with commonly used echocardiographic variables.

293 , which improved to 96.2% with addition of 4 echocardiographic variables.

294 ter adjustment for clinical and conventional echocardiographic variables.

295 AF recurrence apart from other clinical and echocardiographic variables.

296 ts with adjustment for multiple clinical and echocardiographic variables.

297 This study hypothesized that echocardiographic vector flow mapping, a new echocardiog

298 view will describe tricuspid anatomy, define echocardiographic views for evaluating tricuspid valve m

299 om the adjacent RA under direct intracardiac echocardiographic visualization.

300 Echocardiographic Z scores based on BSA were derived fro